These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 18220787

  • 1. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.
    Reddy RN, Mutyala R, Aparoy P, Reddanna P, Reddy MR.
    Curr Pharm Des; 2007; 13(34):3505-17. PubMed ID: 18220787
    [Abstract] [Full Text] [Related]

  • 2. Computer-aided, rational design of a potent and selective small peptide inhibitor of cyclooxygenase 2 (COX2).
    Rajakrishnan V, Manoj VR, Subba Rao G.
    J Biomol Struct Dyn; 2008 Apr; 25(5):535-42. PubMed ID: 18282008
    [Abstract] [Full Text] [Related]

  • 3. Anti-inflammatory drugs in the 21st century.
    Rainsford KD.
    Subcell Biochem; 2007 Apr; 42():3-27. PubMed ID: 17612044
    [Abstract] [Full Text] [Related]

  • 4. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A, Ottani A, Sandrini M.
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [Abstract] [Full Text] [Related]

  • 5. Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1.
    Rimon G, Sidhu RS, Lauver DA, Lee JY, Sharma NP, Yuan C, Frieler RA, Trievel RC, Lucchesi BR, Smith WL.
    Proc Natl Acad Sci U S A; 2010 Jan 05; 107(1):28-33. PubMed ID: 19955429
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Perspective assessment of COX-1 and COX-2 selectivity of nonsteroidal anti-inflammatory drugs from clinical practice: use of genetic function approximation.
    Zambre AP, Ganure AL, Shinde DB, Kulkarni VM.
    J Chem Inf Model; 2007 Jan 05; 47(2):635-43. PubMed ID: 17256838
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential binding mode of diverse cyclooxygenase inhibitors.
    Llorens O, Perez JJ, Palomer A, Mauleon D.
    J Mol Graph Model; 2002 Mar 05; 20(5):359-71. PubMed ID: 11885959
    [Abstract] [Full Text] [Related]

  • 12. Molecular docking-guided synthesis of NSAID-glucosamine bioconjugates and their evaluation as COX-1/COX-2 inhibitors with potentially reduced gastric toxicity.
    Jones Lipinski RA, Thillier Y, Morisseau C, Sebastiano CS, Smith BC, Hall CD, Katritzky AR.
    Chem Biol Drug Des; 2021 Jul 05; 98(1):102-113. PubMed ID: 33955172
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs.
    Mitchell JA, Warner TD.
    Nat Rev Drug Discov; 2006 Jan 05; 5(1):75-86. PubMed ID: 16485347
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. New directions in cyclooxygenase research and their implications for NSAID-gastropathy.
    Flower RJ.
    Ital J Gastroenterol; 1996 Dec 05; 28 Suppl 4():23-7. PubMed ID: 9032578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.